11 /100
LOW RISK
Score updated Jul 13, 2026

MELI — MercadoLibre, Inc. Dilution Risk Tracker

Track MELI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MELI — Get alerts when the score changes →

As of July 13, 2026, MercadoLibre, Inc. (MELI) has a DilutionWatch DilutionScore of 11/100, rated LOW dilution risk. MercadoLibre, Inc. has a market capitalization of $85.96B, 50.70M shares outstanding, 1464 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MELI.
🔔 Track MELI — Get forecast alerts →

💹 Market Data

Market Cap$85.96B
Shares Outstanding50.70M
Float47.04M
Cash$5.65B
Debt$9.93B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 13.4% shares (2026Q1 vs prior)
1464 institutional holders · 49.76M shares
#1 MORGAN STANLEY 5.30M shares
#2 BAILLIE GIFFORD & CO 3.23M shares
#3 Capital Research Global Investors 2.72M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.00M
Days to Cover2.1
% of Float2.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2021
4 INSIDER TRANSACTION Mar 02, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MELI Shareholders

MercadoLibre, Inc. (MELI) has a DilutionScore of 11/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MELI shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MELI in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MELI alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MELI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MELI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MELI
📊 MELI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MELI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.